MANULIFE-S (00945) announced plans to launch a "regular issuer offer" program.

Manulife-S (00945) announced plans to launch a "normal course issuer bid" program, subject to approval by the Toronto Stock Exchange. The program will allow Manulife to repurchase and cancel up to a maximum of 42 million common shares, equivalent to approximately 2.5% of the common shares currently issued and outstanding by Manulife. The Office of the Superintendent of Financial Institutions Canada has approved this "normal course issuer bid" program. As of January 31, 2026, Manulife has a total of 1.6767 billion common shares issued and outstanding. Through the "normal course issuer bid" program, Manulife can flexibly repurchase common shares as part of its capital management strategy. This strategy aims to maintain a strong regulatory capital ratio while also aiming to create value for shareholders.